Peripheral tolerance induction to atloantigen in the mature immune system remains an elusive goal. A number of maneuvers which interfere with signal 1 (antigen receptors), signal 2 (costimulatory receptors), so-called signal 3 (inflammatory cytokines), or antigen processing can result in prolonged or indefinite allograft survival via mechanisms including clonal abortion, deletion, anergy, deviation, and/or agnes/a. It is not certain which methods, mechanisms, cells or molecules are most relevant for achieving nontoxic, long- lived, alloantigen specific tolerance, free from chronic immunosuppression and chronic rejection. The general failure to reach these goals suggests that there are additional levels of immune regulation. It is noteworthy that the majority of approaches to tolerance have examined molecular and cellular mechanisms in vitro, or graft survival in vivo, without regard to structural and anatomic compartmentalization that may dictate additional levels of regulation. Therefore, the definition of the anatomic domains where alloantigen is presented to induce tolerance, and where lymphocytes interact with antigen and immunosuppressants to become tolerized (deleted, anergized, deviated, ignorant) are likely to be critical determinants of the tolerization process. Our preliminary data demonstrate that T lymphocytes must utilize L-selectin to remain in the lymph node in order to induce alloantigen specific tolerance in models that perturb signal 1 or signal 2. We hypothesize that lymph node homing and localization are required for peripheral tolerance induction, and that the lymph node domain is uniquely suited to peripheral, alloantigen specific tolerance. Corollaries are that localization of T lymphocytes to other compartments, or lymph node depletion of T lymphocytes, will prevent peripheral tolerance induction. Additional implications are that quantitative distribution, such as the ratio or absolute number of T cells in lymph nodes versus other compartments (e.g., peripheral blood, spleen), and temporal distribution during toierization regimens determine the balance between immunity and tolerance.
The Specific Aims will investigate this hypothesis as follows: 1) Determine why inhibition of CD62L dependent T cell LN homing prevents tolerance. 2) Determine what other receptors and ligands are important for T cell homing and tolerance induction. 3) Determine the role of specific anatomic sites during tolerance induction.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI041428-09
Application #
7158586
Study Section
Surgery, Anesthesiology and Trauma Study Section (SAT)
Program Officer
Kehn, Patricia J
Project Start
1997-07-01
Project End
2008-06-14
Budget Start
2006-12-01
Budget End
2008-06-14
Support Year
9
Fiscal Year
2007
Total Cost
$281,255
Indirect Cost
Name
Mount Sinai School of Medicine
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
078861598
City
New York
State
NY
Country
United States
Zip Code
10029
Simon, Thomas; Bromberg, Jonathan S (2017) Regulation of the Immune System by Laminins. Trends Immunol 38:858-871
Lal, Girdhari; Kulkarni, Neeraja; Nakayama, Yumi et al. (2016) IL-10 from marginal zone precursor B cells controls the differentiation of Th17, Tfh and Tfr cells in transplantation tolerance. Immunol Lett 170:52-63
Xiong, Yanbao; Ahmad, Sarwat; Iwami, Daiki et al. (2016) T-bet Regulates Natural Regulatory T Cell Afferent Lymphatic Migration and Suppressive Function. J Immunol 196:2526-40
Nakayama, Yumi; Brinkman, C Colin; Bromberg, Jonathan S (2015) Murine Fibroblastic Reticular Cells From Lymph Node Interact With CD4+ T Cells Through CD40-CD40L. Transplantation 99:1561-7
Pierson 3rd, Richard N; Bromberg, Jonathan S (2015) Alloantibodies and Allograft Arteriosclerosis: Accelerated Adversity Ahead? Circ Res 117:398-400
Lal, Girdhari; Nakayama, Yumi; Sethi, Apoorva et al. (2015) Interleukin-10 From Marginal Zone Precursor B-Cell Subset Is Required for Costimulatory Blockade-Induced Transplantation Tolerance. Transplantation 99:1817-28
Burrell, Bryna E; Warren, Kristi J; Nakayama, Yumi et al. (2015) Lymph Node Stromal Fiber ER-TR7 Modulates CD4+ T Cell Lymph Node Trafficking and Transplant Tolerance. Transplantation 99:1119-25
Iwami, Daiki; Brinkman, C Colin; Bromberg, Jonathan S (2015) Vascular endothelial growth factor c/vascular endothelial growth factor receptor 3 signaling regulates chemokine gradients and lymphocyte migration from tissues to lymphatics. Transplantation 99:668-77
Warren, Kristi J; Iwami, Daiki; Harris, Donald G et al. (2014) Laminins affect T cell trafficking and allograft fate. J Clin Invest 124:2204-18
Brinkman, C Colin; Burrell, Bryna E; Iwami, Daiki et al. (2013) Anatomy of tolerance. Curr Opin Organ Transplant 18:393-401

Showing the most recent 10 out of 42 publications